Intal therapy in non-atopic bronchial diseases
Krawczyk, Z.; Pilarska-Machowicz, A.; Górnicka-Wilczyńska, M.; Pruszyńska, S.
Pneumonologia Polska 47(5): 327-332
1979
ISSN/ISBN: 0376-4761 PMID: 112586 Document Number: 152709
Document emailed within 1 workday
Related Documents
Wasek, Z.; Plusa, T.; Ligeziński, A. 1974: Intal in the treatment of atopic extrinsic bronchial asthma. I. Effect on the ventilatory function Gruzlica i Choroby Pluc; Tuberculosis et Pneumonologia 42(12): 1137-1141Szczeklik, A.; Adamek, T.; Czerniawska-Mysik, G.; Maternowska, W. 1974: Results of prolonged intal therapy in patients with bronchial asthma Przeglad Lekarski 31(7): 714-716
Nowak, D.; Magnussen, H. 1987: Ketotifen (Zaditen) and disodium cromoglycinic acid (Intal) in the therapy of bronchial asthma Praxis und Klinik der Pneumologie 41(9): 319-323
Románski, B.; Pawlik-Miskiewicz, K.; Wilewska-Klubo, T. 1983: Clinical studies on the protective effects of Ketotifen and Intal in atopic asthmatic patients Allergologia et Immunopathologia 11(1): 34-39
Stasiak-Barmuta, A.; Puchnarewicz, A.; Hofman, J. 1998: TFX hormone in the therapy of non-atopic bronchial concomitant asthma with pleuropneumonia Polski Merkuriusz Lekarski: Organ Polskiego Towarzystwa Lekarskiego 4(23): 275-276
Mijatović, M. 1975: Treatment of bronchial asthma by disodium cromoglycate (Intal) Vojnosanitetski Pregled 32(3): 297-299
Rogala, E.; Potocka-Skowronek, Z.; Socha, B.; Dwornicki, J.; Zawisza, K. 1981: Effect of disodium cromoglycate (Intal) on the course of endogenous steroid-dependent bronchial asthma Pneumonologia Polska 49(4): 291-294
Hałuszka, J.; Sciślicki, A.; Rudnik, J. 1982: Intal in the treatment of bronchial asthma in children. II. Physical characteristics of the respiratory system Pediatria Polska 57(11): 881-889
Scherrer, M. 1974: Place of Cromolyn (Lomudal, Intal, Aarane) in the treatment-plan for bronchial asthma Therapeutische Umschau. Revue Therapeutique 31(11): 823-828
Adam, D.; Ferlinz, R.; Frei, R.; Geisler, L.; Knothe, H.; Lode, H.; Shah, P. 1992: Antibacterial therapy in infectious bronchial diseases. Recommendations of the German League for control of respiratory tract diseases Medizinische Monatsschrift für Pharmazeuten 15(4): 100-105
Barliński, J.; Droszcz, W.; Wrońska, J. 1986: Protective effect of nifedipine on histamine-induced bronchial spasm in patients responding and not responding to Intal treatment Wiadomosci Lekarskie 39(14): 942-945
1979: Non-tuberculous pulmonary and bronchial diseases. The rhino-pulmonary syndrome. Pneumonias. Diagnosis and therapy of diseases of the airways Zfa. Zeitschrift für Allgemeinmedizin 55(24): 1307-1309
Irmer, V.; Christ, R. 1980: Value of disodium cromoglycate (INTAL) in the treatment of obstructive pulmonary diseases Zeitschrift für Erkrankungen der Atmungsorgane 154(3): 308-312
Palumbo-Vargas, O. 1971: On the therapy of cough in bronchial diseases of children Minerva Medica 62(17): 833-836
Barandun, J. 1996: Inhalation therapy in chronic obstructive bronchial diseases Schweizerische Medizinische Wochenschrift 126(40): 1693-1703
Werner, M. 1973: The diagnosis and therapy of allergic factors in bronchial diseases Medizinische Klinik 68(49): 1630-1635
Barthel, E. 1983: Current dosed aerosols in the treatment of obstructive respiratory tract diseases. 1. Intal Zeitschrift für Arztliche Fortbildung 77(17): 721-723
1998: New findings on the pathogenesis and therapy of inflammatory diseases of the bronchial system Der Internist 39(1 Suppl Neues Zur): 1-8
Salob, S.P.; Laverty, A.; Atherton, D.J. 1993: Bronchial hyperresponsiveness in children with atopic dermatitis Pediatrics 91(1): 13-16
Lewandowska, J.; Wartenberg, J.; Sadowska, L.; Domanasiewicz, M.; Boznański, A. 1982: Atopic dermatitis and bronchial asthma in children Polski Tygodnik Lekarski 37(23): 665-668